Jeffrey Robert Ajer - Apr 13, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Apr 13, 2022
Transactions value $
-$97,315
Form type
4
Date filed
4/14/2022, 07:54 PM
Previous filing
Mar 31, 2022
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale -$97.3K -1.18K -2.1% $82.47 55.1K Apr 13, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on February 28, 2022.